Shattuck Labs Inc/ US82024L1035 /
| 18/06/2024 21:59:53 | Chg. -0.36 | Volume | Bid- | Ask- | High | Low |
|---|---|---|---|---|---|---|
| 4.60USD | -7.26% | 19,546 Turnover: 90,650.69 |
-Bid Size: - | -Ask Size: - | 5.01 | 4.54 |
GlobeNewswire
14/06
Shattuck Labs Announces Updated Positive Interim Data from the Phase 1B Dose Expansion Clinical Tria...
GlobeNewswire
10/06
Shattuck Labs Announces Orphan Drug Designation Granted by the U.S. Food and Drug Administration (FD...
GlobeNewswire
06/06
Shattuck Labs to Host Investor Call and Webcast on Additional Interim Data Presented at the European...
GlobeNewswire
14/05
Shattuck Labs to Present Additional Data from the Phase 1B Dose Expansion Clinical Trial of SL-17215...
GlobeNewswire
02/05
Shattuck Labs Reports First Quarter 2024 Financial Results and Recent Business Highlights
GlobeNewswire
09/04
Shattuck Labs Announces Oral Presentation of Preclinical Data at the American Association for Cancer...
GlobeNewswire
01/04
Shattuck Labs Announces Participation in Upcoming 23rd Annual Needham Virtual Healthcare Conference
GlobeNewswire
04/03
Shattuck Labs Announces Appointment of Clay Siegall, Ph.D., and Kate Sasser, Ph.D., to its Board of ...
GlobeNewswire
29/02
Shattuck Labs Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highli...
GlobeNewswire
13/02
Shattuck Labs Enters into Strategic Collaboration and License Agreement with Ono Pharmaceutical to G...
GlobeNewswire
04/01
Shattuck Labs Announces Presentation at Upcoming 42nd Annual J.P. Morgan Healthcare Conference
GlobeNewswire
21/12/2023
Shattuck Labs Announces $50 Million Public Offering of Common Stock and Concurrent Private Placement...
GlobeNewswire
13/12/2023
Shattuck Labs Announces Positive Initial Topline Data from Ongoing Phase 1 A/B Dose Expansion Clinic...
GlobeNewswire
05/12/2023
Shattuck Labs to Host Investor Call and Webcast to Share Initial Clinical Trial Data from Phase 1A/B...
GlobeNewswire
14/11/2023
Shattuck Labs Announces Participation in Upcoming 6th Annual Evercore ISI HealthCONx Conference
GlobeNewswire
09/11/2023
Shattuck Labs Reports Third Quarter 2023 Financial Results and Recent Business Highlights
GlobeNewswire
06/11/2023
Shattuck Labs to Report Third-Quarter 2023 Financial Results on November 9, 2023
GlobeNewswire
02/11/2023
Shattuck Labs to Present Topline Data from Phase 1 A/B Clinical Trial of SL-172154 in Relapsed/Refra...
GlobeNewswire
29/03/2022
Scott+Scott Attorneys at Law LLP Reminds Investors of a Securities Class Action Filed Against Shattu...
GlobeNewswire
28/03/2022
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sta...
GlobeNewswire
27/03/2022
STTK FINAL DEADLINE NOTICE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Shattuck Labs, Inc. Investors ...
GlobeNewswire
25/03/2022
Scott+Scott Attorneys at Law LLP Reminds Investors of a Securities Class Action Filed Against Shattu...
